Financial Performance - Net sales for Q3 2022 were $492.2 million, a 9.6% increase from $449.1 million in Q3 2021[11]. - Gross profit for the nine months ended September 30, 2022, was $456.4 million, slightly up from $455.8 million in the same period of 2021[11]. - Operating income decreased to $44.6 million in Q3 2022 from $36.0 million in Q3 2021, while for the nine months it was $105.9 million, down from $119.7 million[11]. - Net income attributable to Quaker Chemical Corporation for Q3 2022 was $25.9 million, compared to $31.1 million in Q3 2021, reflecting a decline of 16.9%[11]. - For the nine months ended September 30, 2022, consolidated total revenue reached $1,458.8 million, a 10.9% increase from $1,314.1 million in the same period of 2021[54]. - Revenue from the Americas segment was $700.5 million, up 24.6% from $562.8 million in the prior year[54]. - The Company reported total segment operating earnings of $108.951 million for the three months ended September 30, 2022, compared to $95.374 million in Q3 2021, reflecting a 14.2% increase[44]. - The Company’s Global Specialty Businesses segment reported net sales of $101.094 million for Q3 2022, up from $77.373 million in Q3 2021, marking a 30.5% increase[44]. - Basic earnings per common share for Q3 2022 was $1.44, down from $1.74 in Q3 2021, representing a decrease of 17.3%[88]. - Non-GAAP earnings per diluted share for the third quarter of 2022 were $1.74, up from $1.63 in the prior year quarter[136]. Cash Flow and Assets - Cash and cash equivalents decreased to $138.9 million as of September 30, 2022, from $165.2 million at the end of 2021[16]. - Total assets decreased to $2.83 billion as of September 30, 2022, from $2.96 billion at the end of 2021[16]. - Cash flows from operating activities for the nine months ended September 30, 2022, resulted in a net cash used of $26.3 million, compared to a net cash provided of $2.5 million in the same period of 2021[19]. - The company experienced a net operating cash outflow of $26.3 million in the first nine months of 2022, compared to a net operating cash flow of $2.5 million in the same period of 2021[138]. - The Company had Amended Credit Facility borrowings outstanding of $941.2 million as of September 30, 2022, compared to $889.6 million under the Original Credit Facility as of December 31, 2021[157]. Debt and Liabilities - Long-term debt increased to $931.5 million as of September 30, 2022, compared to $836.4 million at the end of 2021[16]. - Total debt as of September 30, 2022, was $954.066 million, an increase of 5.9% from $901.348 million as of December 31, 2021[97]. - The Company recorded a loss on extinguishment of debt amounting to $6.763 million during the nine months ended September 30, 2022[77]. - The cumulative liability for gross unrecognized tax benefits decreased by approximately $6.3 million from December 31, 2021, to $16.2 million as of September 30, 2022[80]. Acquisitions and Investments - In January 2022, the company acquired a business for approximately $8.0 million, enhancing its product offerings in the Americas region[28]. - In October 2022, Quaker Chemical Corporation acquired a business for approximately $3.5 million, strengthening its position in pickling inhibitors and additives[26]. - The Company acquired a tin-plating solutions business for $25.0 million, allocating $19.6 million to intangible assets and recording $5.0 million of goodwill[36]. - The acquisition of Baron Industries in November 2021 was valued at $11.0 million, with potential earn-out provisions totaling up to $4.5 million[31]. Operational Challenges - The company continues to face challenges from ongoing inflationary pressures, supply chain issues, and geopolitical factors, impacting its operations and market conditions[135]. - The decline in organic sales volumes was 9%, attributed to softer end market conditions, particularly in Europe and Asia/Pacific[135]. - The Company continues to monitor various financial, economic, and geopolitical conditions that could impact future performance, including the ongoing Russia-Ukraine war[92]. Tax and Regulatory Matters - The company's effective tax rates for the three and nine months ended September 30, 2022, were 28.1% and 19.2%, respectively, compared to 2.6% and 21.8% for the same periods in 2021[79]. - The company recognized a net benefit to the tax provision of $1.9 million during the first nine months of 2022 due to the settlement of tax audits[87]. - The Company expects to reduce its cumulative liability for gross unrecognized tax benefits by approximately $4.1 million during the year ending December 31, 2022[83]. Strategic Initiatives - The QH Program aims to reduce total headcount by approximately 400 people globally, with ongoing reductions expected into 2023[59]. - The Company expects continued operating costs and cash flows related to strategic planning and transformation expenses in 2022 and extending into the next several years[159]. - The Company incurred strategic planning and transformation expenses of $4,545 thousand in Q3 2022, compared to no such expenses in Q3 2021[174]. Miscellaneous - The Company believes its existing cash and anticipated cash flows will be sufficient to support operations and fund business objectives for at least the next twelve months, including ongoing acquisition integration and capital expenditures[163]. - The Company recorded $10.4 million in total Combination, integration, and other acquisition-related expenses in the first nine months of 2022, down from $13.6 million in the same period of 2021[159].

Quaker Chemical Corporation (NYSE:KWR) Q2 2022 Earnings Conference Call August 5, 2022 8:30 AM ET Company Participants Jeffrey Schnell - Senior Director of Investor Relations Andy Tometich - Chief Executive Officer and President Shane Hostetter - Senior Vice President and Chief Financial Officer Conference Call Participants David Begleiter - Deutsche Bank Pete Lukas - CJS Securities Mike Harrison - Seaport Research Dan Rizzo - Jefferies Operator Greetings, and welcome to the Quaker Houghton Second Quarter 2 ...

Quaker Houghton Second Quarter 2022 Results Investor Conference Call Quaker Houghton.. Forward Together Forward-Looking Statements Regulation G The attached charts include Company information that does not conform to generally accepted accounting principles ("GAAP"). Management believes that an analysis of this data is meaningful to investors because it provides insight with respect to ongoing operating results of the Company and helps investors to evaluate the financial results of the Company. These measur ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, $1 par value ...

Quaker Houghton (NYSE:KWR) Q1 2022 Earnings Conference Call May 6, 2022 8:30 AM ET Company Participants Andy Tometich – Chief Executive Offficer, President Jeffery Snow – Senior Director of Investor Relations Shane Hostetter – Senior Vice President, Chief Financial Officer Robert Traub – General Counsel Conference Call Participants David Begleiter – Deutsche Bank Pete Lucas – CJS Securities Mike Harrison – Seaport Global Dan Rizwan – Jefferies Operator Greetings, and welcome to Quaker Houghton first quarter ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 QUAKER CHEMICAL CORPORATION (Exact name of Registrant as specified in its charter) Pennsylvania 23-0993790 (State or other jurisdiction of incorporation or organization) 901 E. Hector Street, Conshohocken, Pennsylvania 19428 – 2380 (Address of principal executive offices) (Zip Code) (I.R.S. E ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-12019 QUAKER CHEMICAL CORPORATION (Exact name of registrant as specified in its charter) A Pennsylvania Corporation No. 23-0993790 (State or oth ...

Forward Together ™ Quaker Houghton Investor Presentation November 2021 Quaker Houghton.. Forward Together Risks and Uncertainties Statement Regulation G The attached charts include Company information that does not conform to generally accepted accounting principles ("GAAP"). Management believes that an analysis of this data is meaningful to investors because it provides insight with respect to ongoing operating results of the Company and helps investors to evaluate the financial results of the Company. The ...

Quaker Chemical Corporation (NYSE:KWR) Q3 2021 Earnings Conference Call November 5, 2021 8:30 AM ET Company Participants Michael Barry - Chairman, CEO & President Andy Tometich - CEO Shane Hostetter - CFO Robert Traub - General Counsel David Will - Global Controller Conference Call Participants Mike Harrison - Seaport Research David Begleiter - Deutsche Bank Pete Lucas - CJS Securities Marisa Hernandez - Sidoti and Company Garo Norian - Palisade Capital Management Operator Greetings and welcome to the Quake ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-12019 QUAKER CHEMICAL CORPORATION Pennsylvania 23-0993790 (State or other jurisdiction of incorporation or organization) 901 E. Hector ...